G6 Materials Air Purifier Prototype Reduces Pathogenic Microorganisms by 99.9% in Antimicrobial Efficacy Test
The Test Results Demonstrate Significant Utility and Commercialization Potential for the Company’s Technology
Ronkonkoma, New York, USA - TheNewswire – September 7, 2021 - G6 Materials Corp. (“G6” or the “Company”) (TSXV: GGG, OTCQB: GPHBF),
Two different pathogens were randomly chosen to be tested under each experiment, which were the E. coli bacteria and the Phi-X174 bacteriophage. The duration of the Lab Test was set to two hours. The Test Results were documented in an Efficacy Test Report (the “Test Report”) that has been received by the Company and summarized below:
|Organism Type:||Small, Non-Enveloped Virus||Bacteria|
|Organism Name:||Phi-X174 bacteriophage||E. coli|
|Organism Source:||Carolina Bioscience||ATCC|
|Temperature Min./Max.:||21° C (70° F)||21° C (70° F)|
|Humidity Min./Max.:||55% RH||60% RH|
The Company began developing the proprietary technology contained in the graphene-based air purification prototype in early 2020. The first successful implementation of G6’s unique approach to allow for the incorporation of graphene oxide in an air filtration system for the purpose of improving its antimicrobial performance was previously announced on April 1, 2020. Since that time, the Company has filed a provisional patent application that summarizes its proprietary approach.
The global air purifier market size was valued at US$10.67 billion in 2020 and is expected to expand at a compound annual growth rate of 10.0% from 2021 to 2028, according to the Market Analytic Report by Grand View Research.
“We are excited to receive these positive results from a respected independent laboratory. Now, we are eager to take the next steps toward the commercialization of this technology, including obtaining all necessary licenses, government approvals and accreditations to enable us to bring the product to the market. Currently, we are finalizing the plans to manufacture the graphene- enhanced air purifier and are preparing its initial marketing campaign, more information about which will be announced in the future,” said Daniel Stolyarov, President & CEO of G6 Materials Corp. “I am very proud of our team and appreciate the hard work and dedication that was required from each of them in order to reach this point. We are also proud to develop a product that is capable of making our homes and offices safer in these difficult times,” added Mr. Stolyarov.
The Intertek Group plc (“Intertek”) is a leading Total Quality Assurance provider to industries worldwide. Its network of more than 1,000 laboratories and offices, in more than 100 countries, delivers innovative and bespoke Assurance, Testing, Inspection and Certification solutions for customers operations and supply chains. Intertek’s Total Quality Assurance expertise is delivered consistently with precision, pace and passion, thereby enabling customers to power ahead safely. For more information, please visit: http://www.intertek.com.
About G6 Materials Corp.
G6 Materials Corp. is a technology company creating value through the development of innovative graphene-based solutions. Graphene Laboratories Inc., a wholly owned subsidiary of G6, sells a range of graphene-based products and other materials, including but not limited to conductive epoxies, high performance composites and R&D materials, with numerous customers from among the Fortune 500 list of companies, as well as NASA and leading universities. Graphene Laboratories Inc. is developing other innovative products including graphene-enhanced air purifiers and it hopes to enter the global filtration market once all testing is complete and applicable government approvals are received.
G6 has identified new graphene-based applications to accelerate growth into the future. Accordingly, the Company has a valuable IP portfolio currently comprised of five granted patents and five patent applications filed. The Company’s management team and employees have a deep understanding of graphene technology based on decades of aggregate academic and commercial experience. Graphene Laboratories Inc., a wholly owned subsidiary of G6 located in Ronkonkoma, New York, has established its premium research laboratory and scalable production facility is equipped with advanced analytical and material processing equipment.
The Company’s e-commerce websites are listed below:
This news release contains forward-looking statements within the meaning of the applicable securities legislation that is based on expectations, estimates and projections as at the date of this news release. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. “Forward-looking information” in this news release includes information about the acquisition of GX Technologies; the use of proceeds of the Offering; the potential for the Company’s long-term growth; the business goals and objectives of the Company, and other forward-looking information includes but is not limited to information concerning the intentions, plans and future actions of the parties to the transactions described herein and the terms thereon.
Risk factors that could cause actual results to differ materially from those described in such forward-looking information include, but are not limited to, the combined company not being able to expand its pilot facility to produce graphene oxide in Long Island, New York on the terms currently anticipated, or at all; that the combined company may not achieve its key milestones and value drivers in the time estimated, or at all; the risks associated with outstanding litigation, if any; risks associated with adoption by industries of graphene-based products health and environmental factors affecting adoption of these technologies; the company may fail to obtain appropriate government approvals or accreditation related to the business’ operations and technological processes; the market conditions and demand for its product as well as the market prices of such products being developed by the company may change over time; reliance on key personnel; the potential for conflicts of interest among certain officers, directors or promoters with certain other projects; the absence of dividends; competition; dilution; the volatility of our common share price and volume; and tax consequences to U.S. shareholders.
The Company undertakes no obligation to revise or update any forward-looking information other than as required by law.Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Telephone: (631) 405-5113